COX inhibitor Etoricoxib D4, Purity ≥98%

Cat. No.: X23-10-ZQ737

COX inhibitor Etoricoxib D4, Purity ≥98%

Synonym: Etoricoxib D4; 1131345-14-6; Etoricoxib-d4; MK-0663 D4; 5-Chloro-2-(6-methylpyridin-3-yl)-3-(2,3,5,6-tetradeuterio-4-methylsulfonylphenyl)pyridine; COX inhibitor

  • CAS Number: 1131345-14-6
  • Compound CID: 25224662
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Etoricoxib D4 blocks the COX enzymes from converting arachidonic acid to prostaglandins, thereby reducing inflammatory reactions.
Molecular Weight
362.87
Molecular Formula
C18H11D4ClN2O2S
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Etoricoxib D4 is a deuterated form of Etoricoxib used to study COX-2 inhibition and anti-inflammatory effects with improved pharmacokinetic properties.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.